The abstract notes CMA dysregulation is 'increasingly recognized in various cancers' but states mechanisms remain unclear. This suggests a fundamental gap in understanding whether CMA hyperactivation represents a universal cancer hallmark or distinct tissue-specific processes. Gap type: open_question Source paper: Targeting chaperone-mediated autophagy inhibits properties of glioblastoma stem cells and restores anti-tumor immunity. (2026, Nature communications, PMID:41390755)
Landscape Summary: Why does CMA hyperactivation occur broadly across cancers despite tissue-specific contexts? is a 0.75 priority gap in neurodegeneration. It has 0 linked hypotheses with average composite score 0.000. Status: open.
Colonna, Sevlever, et al. (TREM2 biology)
Why does CMA hyperactivation occur broadly across cancers despite tissue-specific contexts? — INVOKE-2 (completed)
No hypotheses linked to this gap yet.
No activity recorded yet.
No discussions yet. Be the first to comment.
Create sub-tasks to investigate specific aspects of this gap: